Xiaoping Wang

79 papers receiving 1.9k citations

Xiaoping Wang's Hit Papers

Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE) 2022 · 162 citations
1620+1+2Years since publication50100150

Peers

Xiaoping Wang
Comparison fields: 5 of 116
  • Hepatology 147
  • Biological Psychiatry 17
  • Nutrition and Dietetics 136
  • Behavioral Neuroscience 29
  • Pulmonary and Respiratory Medicine 270
Replace Munechika Enjoji with:
Munechika Enjoji Japan
Jun Zhu China
Ping Qü China
Oren Rom United States
Hyun Jin Kim South Korea
Nikolaos G Kostomitsopoulos Greece
Ling Liu China
Alessandro Arduini Spain
Claire Greenhill Australia
Yujian Liu China
Xiaoping Wang relative to Munechika Enjoji Japan Munechika Enjoji's profile →
Citations per field
00.5×1.5×1.9×
Munechika Enjoji · 1×
Citations per year

Countries citing papers authored by Xiaoping Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaoping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Wang more than expected).

Fields of papers citing papers by Xiaoping Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Wang. The network helps show where Xiaoping Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaoping Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoping Wang Line = papers co-authored together Xiaoping Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2012171
2
Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE)
Hit paper breakdown →
2022162
3 2017161
4 2014122
5 2018120
6 2011118
7 2006108
8 199962
9 201756
10 199952
11 201549
12 200848
13 201547
14 201843
15 201139
16 201930
17 201528
18 201928
19 201927
20 200126

About Xiaoping Wang

Xiaoping Wang is a scholar working on Hepatology, Immunology, Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research, having authored 81 papers that have together received 2k indexed citations. Recurring topics across this work include Heat shock proteins research (6 papers), Immunotherapy and Immune Responses (5 papers), Scoliosis diagnosis and treatment (4 papers), Liver Disease and Transplantation (4 papers), MicroRNA in disease regulation (4 papers), Medicinal Plants and Bioactive Compounds (4 papers), Virus-based gene therapy research (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). The work is most often cited by research in Hepatology (147 citations), Biological Psychiatry (17 citations), Nutrition and Dietetics (136 citations), Behavioral Neuroscience (29 citations) and Pulmonary and Respiratory Medicine (270 citations). Xiaoping Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Huanping Lin, Yan Gu, Huiling Wang, Guo‐Chong Chen, Li‐Qiang Qin, Jiaping Chen, Yanjie Bai, Yuanyuan Ye, Keith M. Bagnall and James K. Mahood. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Canadian Journal of Gastroenterology and Hepatology, World Journal of Surgery, Cancer Biotherapy and Radiopharmaceuticals and Journal of Surgical Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact